Xiao Yang,1 Shaoming Zhu,2 Li Li,3 Li Zhang,1 Shu Xian,1 Yanqing Wang,1 Yanxiang Cheng1 1Department of Obstetrics and Gynecology, 2Department of Urology, Renmin Hospital of Wuhan University, 3Department of Pharmacology, Wuhan University Health Science Center, Wuhan, Hubei, People’s Republic of China Background: The mortality rate associated with ovarian cancer ranks the highest among gynecological malignancies. However, the cause and underlying molecular events of ovarian cancer are not clear. Here, we applied integrated bioinformatics to identify key pathogenic genes involved in ovarian cancer and reveal potential molecular mechanisms. Results: The expression profiles of GDS3592, GSE54388, and GSE66957 were downloaded fro...
Abstract Background Epithelial ovarian cancer is one of the most severe public health threats in wo...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
SummaryBackgroundHuman ovarian carcinoma is a silent killer. Most patients with human ovarian carcin...
Abstract Background Ovarian cancer is one of the most common gynecological tumors, and among gynecol...
Abstract Ovarian cancer (OC) is the highest frequent malignant gynecologic tumor with very complicat...
Ovarian cancer (OC) is the seventh most commonly detected cancer among women. This study aimed to ma...
Background: Epithelial Ovarian Cancer (EOC) has remained the most frequent and leading cause of deat...
Objective: The current research was aimed to identify candidate genes associated with development an...
Background: Ovarian cancer is one of the rarest lethal oncologic diseases that have hardly any speci...
Abstract Background Ovarian cancer is a leading cause of the death from gynecologic malignancies. Hy...
BackgroundThough considerable efforts have been made to improve the treatment of epithelial ovarian ...
Ovarian Cancer (OVCA) is the most occurring gynecological cancer worldwide, often diagnosed at a lat...
Abstract Background This study aimed to explore and identify key genes and signaling pathways that c...
Youzheng Xu, Keng Shen Department of Obstetrics and Gynecology, Peking Union Medical College Hospita...
Abstract Background Ovarian cancer (OC) is a gynecological oncology that has a poor prognosis and hi...
Abstract Background Epithelial ovarian cancer is one of the most severe public health threats in wo...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
SummaryBackgroundHuman ovarian carcinoma is a silent killer. Most patients with human ovarian carcin...
Abstract Background Ovarian cancer is one of the most common gynecological tumors, and among gynecol...
Abstract Ovarian cancer (OC) is the highest frequent malignant gynecologic tumor with very complicat...
Ovarian cancer (OC) is the seventh most commonly detected cancer among women. This study aimed to ma...
Background: Epithelial Ovarian Cancer (EOC) has remained the most frequent and leading cause of deat...
Objective: The current research was aimed to identify candidate genes associated with development an...
Background: Ovarian cancer is one of the rarest lethal oncologic diseases that have hardly any speci...
Abstract Background Ovarian cancer is a leading cause of the death from gynecologic malignancies. Hy...
BackgroundThough considerable efforts have been made to improve the treatment of epithelial ovarian ...
Ovarian Cancer (OVCA) is the most occurring gynecological cancer worldwide, often diagnosed at a lat...
Abstract Background This study aimed to explore and identify key genes and signaling pathways that c...
Youzheng Xu, Keng Shen Department of Obstetrics and Gynecology, Peking Union Medical College Hospita...
Abstract Background Ovarian cancer (OC) is a gynecological oncology that has a poor prognosis and hi...
Abstract Background Epithelial ovarian cancer is one of the most severe public health threats in wo...
Background: Human ovarian carcinoma is a silent killer. Most patients with human ovarian carcinoma a...
SummaryBackgroundHuman ovarian carcinoma is a silent killer. Most patients with human ovarian carcin...